News
While Amgen’s monthly obesity candidate MariTide helped patients lose significant amounts of weight in a phase 2 study, ...
In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained ...
For instance, survivors with cancers related to obesity often face higher risks for cancer recurrence and death—not just from ...
Study explains increased risk of metabolic disorders in children born to obese mothers. Children born to obese mothers face a ...
MDR-001 achieved statistically significant weight reductions of 8.2% to 10.3% at 24 weeks compared to 2.5% with placebo ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...
Head-splitting migraines could be the next ailment in a seemingly endless list that a class of blockbuster weight-loss drugs ...
Spain’s ministry of health has asked Novo Nordisk for clarification about a controversial obesity awareness campaign which may have broken the country’s law on promoting prescription drugs. The ...
LSU’s Pennington Biomedical Research Center is working to prevent and treat childhood obesity in the state through its Greaux ...
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback